NCT01219309View on ClinicalTrials.gov

Omega-3/Omega-6 Fatty Acids for Attention-Deficit/Hyperactivity Disorder (ADHD): A Trial in Children and Adolescents

PHASE3CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

June 30, 2006

Study Completion Date

April 30, 2007

Conditions
ADHDReading/Writing Disorder
Interventions
DIETARY_SUPPLEMENT

Omega 3/6 fatty acids

3 capsules bid orally

DIETARY_SUPPLEMENT

Placebo (olive oil)

3 capsules bid orally

Sponsors

Collaborators (1)

Vifor Pharma
All Listed Sponsors
collaborator

Vifor Pharma

INDUSTRY

lead

Göteborg University

OTHER